|
Abbott to Develop CDx for AstraZeneca Asthma Drug
GenomeWeb NEW YORK (GenomeWeb) – AstraZeneca has inked an agreement with Abbott to develop companion diagnostic tests to identify patients with severe asthma who are most likely to benefit from the investigational therapy, tralokinumab, developed by … AstraZeneca (AZN), Abbott (ABT) to Develop Diagnostic Tests for Asthma Patients Diagnostic Tests for Biologic Asthma Therapy Under Development Drugmaker dives into personalized medicine for asthma, heart disease |
View full post on asthma – Google News